It’s about to get harder to find your prescription drugs
At any given time, up to 100 or more — sometimes many more — drugs are not readily available to American patients, largely ...
GlobalData on MSN1 天
Study shows sustainability benefits of UPM and Corning’s pharma packaging
A joint study conducted by UPM Raflatac and Corning Pharmaceutical Technologies has revealed the sustainability and ...
With FDA approval, Genentech turns eye implant's focus to diabetes
Genentech Inc. won regulatory approval Tuesday to market an eye implant that can be refilled every six months with an already ...
Is Regeneron Pharmaceuticals (REGN) the Best Cancer Stock to Buy According to Hedge Funds?
We recently published a list of the 10 Best Cancer Stocks to Buy According to Hedge Funds. In this article, we are going to ...
Insulin prices are falling due to market forces — no price caps required
If California patients pay more than $35 per month for insulin now, it’s in large part because PBMs have rigged the system in ...
STAT3 天
HPV self-collection tests must be approved for use at home
Women’s health champions like us cheered in January when the U.S. Preventive Services Task Force (USPSTF) issued a draft ...
The Sunday Times5 天
NMRA’s new measures bring down medicinal drug prices
The National Medicines Regulatory Authority (NMRA) has started verifying prices directly with global pharmaceutical manufacturers whenever it notices significant discrepancies between the rates quoted ...
Nationwide Blood Pressure Drug Recall As FDA Issues Fatal Warning
An injectable blood pressure drug has been recalled after the FDA has warned it could cause side effects, such as stroke or death.